Crossmark

Position of the Spanish Society of Rheumatology (SER) and the Spanish Society for Bone Research and Mineral Metabolism (SEIOMM) on romosozumab

Crossref DOI link: https://doi.org/10.1016/j.reumae.2021.10.001

Published Print: 2022-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Castañeda, Santos

Gómez-Alonso, Carlos

Graña, Jenaro

Guañabens, Núria

Muñoz-Torres, Manuel

Peris, Pilar

Naves, Manuel

Álvaro-Gracia, José M.
License Information

Text and Data Mining valid from 2022-08-01
More Information

This article is maintained by: Elsevier

Article Title: Position of the Spanish Society of Rheumatology (SER) and the Spanish Society for Bone Research and Mineral Metabolism (SEIOMM) on romosozumab

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2021.10.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2021.10.001

Content Type: article

Copyright: © 2021 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.